Global Asthma and COPD devices Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

By Product;

Inhaler and Nebulizer.

By Indication;

Asthma and Chronic Obstructive Pulmonary Disease.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2020 - 2030).
Report ID: Rn657018088 Published Date: May, 2024 Updated Date: June, 2024


Global Asthma and COPD devices Market (USD Million), 2020 - 2030

In the year 2023, the Global Asthma and COPD devices Market was valued at USD 4,403.38 million. The size of this market is expected to increase to USD 6,097.54 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 4.8%.

Asthma and Chronic Obstructive Pulmonary Disease (COPD) are among the most prevalent respiratory conditions globally, presenting significant challenges to healthcare systems and individuals alike. These conditions, characterized by airway inflammation and obstruction, pose a considerable burden on public health due to their high prevalence, morbidity, and economic impact. As a result, the development and utilization of advanced medical devices tailored to managing these diseases have become increasingly crucial.

The Global Market for Asthma and COPD devices encompasses a diverse range of products, including inhalers, nebulizers, peak flow meters, and spirometers, among others. These devices play a pivotal role in symptom management, disease monitoring, and improving patients' quality of life. With ongoing technological advancements and a growing emphasis on personalized healthcare, the market for these devices continues to evolve rapidly, offering innovative solutions to address the complex needs of patients and healthcare providers.

In this comprehensive report, we delve into the dynamics shaping the global asthma and COPD devices market, examining key trends, drivers, challenges, and opportunities. Through a thorough analysis of market segments, geographical regions, and competitive landscapes, we aim to provide valuable insights to stakeholders, including manufacturers, healthcare professionals, investors, and policymakers. By understanding the current landscape and future prospects of this market, stakeholders can make informed decisions to drive innovation, improve patient outcomes, and contribute to the overall advancement of respiratory healthcare on a global scale.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Indication
    3. Market Snapshot, By Region
  4. Global Asthma and COPD devices Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising respiratory disease prevalence
        2. Increased respiratory health awareness
        3. Aging population and healthcare spending
        4. Shift to home-based care
        5. Pollution-induced respiratory issues
      2. Restraints
        1. Stringent regulatory requirements
        2. Limited healthcare access
        3. Safety concerns
        4. Resistance to change
      3. Opportunities
        1. Drug-device combination innovation
        2. Digital health integration
        3. Value-based healthcare models
        4. AI and machine learning adoption
        5. Device usability enhancement
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Asthma and COPD devices Market, By Product, 2020 - 2030 (USD Million)
      1. Inhaler
      2. Nebulizer
    2. Global Asthma and COPD devices Market, By Indication, 2020 - 2030 (USD Million)
      1. Asthma
      2. Chronic Obstructive Pulmonary Disease
    3. Global Asthma and COPD devices Market, By Geography, 2020 - 2030 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. GlaxoSmithKline plc
      2. AstraZeneca plc
      3. Boehringer Ingelheim International GmbH
      4. Novartis International AG
      5. Teva Pharmaceutical Industries Ltd.
      6. Philips Healthcare
      7. Merck & Co., Inc.
      8. 3M Health Care
      9. Omron Corporation
      10. ResMed Inc.
      11. Smiths Medical
      12. Fisher & Paykel Healthcare Limited
      13. Sunovion Pharmaceuticals Inc.
      14. Circassia Pharmaceuticals plc
      15. CareFusion Corporation (now part of Becton, Dickinson and Company)
  7. Analyst Views
  8. Future Outlook of the Market